#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12954	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2279	566.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1533	1533	C	750	C,A,T	686,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12954	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2279	566.4	0	HET	.	.	.	G79A	.	79	79	G	428	428	G	742	G,A	555,143	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23674	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3527	668.2	0	.	n	.	0	T695C	SNP	695	695	T	1079	1079	C	701	C,T,A	654,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23674	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3527	668.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1721	1721	A	772	A	726	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23674	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3527	668.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2355	2355	C	764	C,T,A	715,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23674	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3527	668.2	0	.	n	.	0	C2632T	SNP	2632	2632	C	3016	3016	T	744	T,C	691,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23674	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3527	668.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2429	2429	A	806	A	755	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23674	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3527	668.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2981	2981	C	761	C,A	720,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1708	folP	855	855	100.0	folP.l15.c17.ctg.1	1426	118.6	1	SNP	p	R229S	1	.	.	685	687	AGC	967	969	AGC	183;182;180	A;G;C	167;166;165	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4424	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3510	125.6	1	SNP	p	S91F	0	.	.	271	273	TCC	650	652	TCC	143;144;144	T;C;C	135;136;139	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4424	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3510	125.6	1	SNP	p	D95G	0	.	.	283	285	GAC	662	664	GAC	154;155;154	G;A;C	145;144;144	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4424	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3510	125.6	1	SNP	p	D95N	0	.	.	283	285	GAC	662	664	GAC	154;155;154	G;A;C	145;144;144	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1334	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1397	94.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	542	544	ACC	155;154;155	A;C;C	145;148;149	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1334	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1397	94.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	740	742	CAC	154;154;156	C;A;C	144;142;147	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1334	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1397	94.9	1	SNP	p	G45D	0	.	.	133	135	GGC	560	562	GGC	151;150;151	G;G;C	143;140;140	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	690	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1110	62.0	0	.	n	.	0	A210G	SNP	210	210	A	695	695	G	151	G	138	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4414	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3146	139.8	1	SNP	p	D86N	0	.	.	256	258	GAC	718	720	GAC	189;188;191	G;A;C	174;170;176	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4414	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3146	139.8	1	SNP	p	S87I	0	.	.	259	261	AGT	721	723	AGT	191;189;190	A;G,T;T	174;174,1;175	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4414	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3146	139.8	1	SNP	p	S87R	0	.	.	259	261	AGT	721	723	AGT	191;189;190	A;G,T;T	174;174,1;175	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4414	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3146	139.8	1	SNP	p	S87W	0	.	.	259	261	AGT	721	723	AGT	191;189;190	A;G,T;T	174;174,1;175	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4414	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3146	139.8	1	SNP	p	S88P	0	.	.	262	264	TCC	724	726	TCC	187;186;186	T;C;C	171;170;173	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3658	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2757	132.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1630	1632	GGC	178;173;172	G;G;C	167;163;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1170	1172	GCA	176;173;179	G;C;A	164;164;170	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1173	1175	ATC	182;180;182	A;T;C	174;169;167	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1185	1187	GTG	182;180;181	G;T;G	171;167;168	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1185	1187	GTG	182;180;181	G;T;G	171;167;168	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1689	1691	ACC	183;182;182	A;C;C	167;170;172	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1743	1745	GCG	160;160;162	G;C;G	147;132;144	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1743	1745	GCG	160;160;162	G;C;G	147;132;144	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1866	1868	GGC	149;145;145	G;G;C	138;135;135	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1875	1877	GGC	142;141;142	G;G;C	131;130;131	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3422	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2378	143.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1893	1895	CCG	132;130;133	C,G;C;G	104,3;102;105	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4472	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3125	142.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1690	1692	CTG	149;150;150	C;T;G	140;143;143	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1694	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1776	94.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	587	587	C	104	C	101	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	S271T	NONSYN	811	813	TCG	128	130	ACT	15;15;13	A;C;T	14;14;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	Y273N	NONSYN	817	819	TAT	134	136	AAT	6;4;2	A;A;T	6;4;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	137	139	AGT	2;2;2	A;G;T	1;2;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	N277H	NONSYN	829	831	AAC	146	148	CAC	2;2;2	C;A;C	2;1;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	R307E	NONSYN	919	921	AGA	236	238	GAA	5;5;5	G;A;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	248	250	GCA	6;6;6	G;C;A	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	251	253	GAC	7;7;6	G;A;C	7;7;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	257	259	ATC	6;5;5	A;T;C	6;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	263	265	TCG	5;5;5	T;C;G	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	269	271	GCC	5;5;6	G;C;C	5;5;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	272	274	AGC	6;6;6	A;G;C	6;6;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	275	277	GCC	6;6;6	G;C;C	5;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	166	porB1a	984	271	91.14	porB1a.l15.c17.ctg.2	370	9.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	281	283	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	938	940	CAA	217;220;221	C;A;A	205;210;209	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	E212S	NONSYN	634	636	GAA	1145	1147	AGT	207;206;208	A;G,A;T	195;193,2;194	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1148	1150	GAT	208;209;211	G,A;A;T	196,1;193;197	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1154	1156	GCT	211;213;214	G,T,A;C,T;T	201,2,1;202,1;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1163	1165	ATG	216;216;215	A,G;T;G,C	210,1;207;205,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1280	1282	AAG	214;215;215	A;A;G	204;206;205	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1391	1393	AAT	205;205;204	A;A;T	189;189;186	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2536	porB1b	1047	1047	98.76	porB1b.l15.c4.ctg.1	1695	148.8	1	SNP	p	G120K	0	.	.	358	360	GGC	869	871	GGC	211;209;209	G;G;C,T	203;200;199,2	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9216	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4961	185.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1002	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1108	89.8	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	199;197;196	A;T;G	190;188;186	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	11042	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2567	428.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
